- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
TAF15 antibody detects TATA-binding protein-associated factor 2N, an RNA-binding protein that participates in transcription initiation, RNA splicing, and stress granule dynamics. The UniProt recommended name is TATA-binding protein-associated factor 2N (TAF15). This multifunctional protein is a member of the FET family of RNA-binding proteins, which includes FUS and EWSR1, all of which link transcriptional and post-transcriptional gene regulation.
Functionally, TAF15 antibody identifies a 592-amino-acid nuclear protein characterized by RNA recognition motifs (RRMs), a low-complexity prion-like domain, and a glycine-rich C-terminus. TAF15 interacts with the TFIID complex, serving as a coactivator in transcription initiation by RNA polymerase II. It also binds nascent transcripts, coordinating RNA processing and export. Through its prion-like domain, TAF15 can assemble into reversible RNA-protein granules under stress, supporting mRNA storage and translational regulation.
The TAF15 gene is located on chromosome 17q11.2 and is ubiquitously expressed, with particularly high levels in neurons and other transcriptionally active cells. TAF15 acts at the interface of chromatin remodeling and RNA metabolism, modulating transcriptional output and transcript stability. It regulates genes involved in differentiation, cell cycle control, and stress response, serving as a key integrator of nuclear RNA metabolism.
Clinically, TAF15 has been implicated in oncogenic translocations and neurodegenerative disorders. Chromosomal rearrangements involving TAF15 generate fusion oncoproteins such as TAF15-NR4A3 and TAF15-CREB1, which act as aberrant transcriptional activators in sarcomas and leukemia. In the nervous system, abnormal aggregation of TAF15 has been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where it contributes to RNA granule pathology and cytoplasmic mislocalization.
TAF15 antibody is widely used in RNA biology, transcriptional regulation, and neurodegeneration research. It is suitable for immunoblotting, immunofluorescence, and chromatin immunoprecipitation to detect TAF15 localization and activity. This antibody supports studies of RNA processing, stress granule formation, and oncogenic fusions. In translational research, TAF15 detection aids in characterizing RNA-protein interactions and gene expression networks underlying disease.
Structurally, TAF15 combines RNA-binding RRMs with intrinsically disordered regions that mediate multivalent interactions with RNA and chromatin-associated proteins. NSJ Bioreagents provides TAF15 antibody reagents validated for use in transcriptional regulation, RNA processing, and neurodegenerative disease research.
Optimal dilution of the TAF15 antibody should be determined by the researcher.
E.coli-derived human TAF15 recombinant protein (Position: Y63-R395) was used as the immunogen for the TAF15 antibody.
After reconstitution, the TAF15 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.